OCEA
Ocean Biomedical, Inc.
0.00 (0.00%)0.00USD600成交股數232K市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | −433K+48% | −461K-31% | −515K+71% | −637K-43% | −293K+380% | −668K+1263% | −301K+1781% | −1.1M | −61K | −49K | −16K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 18K | – | – | – | 26K | 305K | 28K | 393K | 161K | 1.9M | 3.2M | 3.2M |
| 銷售管理費用 | 940K | 1.8M | 768K | 682K | 569K | 2.4M | 2.8M | 5.0M | 777K | 1.3M | 3.7M | 1.9M |
| 營業利益 | −958K+61% | −1.8M-34% | −768K-73% | −682K-87% | −595K-37% | −2.7M-16% | −2.8M-59% | −5.4M+5% | −938K | −3.2M | −6.9M | −5.1M |
| 營業利益率 | – | 404.8% | 166.6% | 132.4% | 93.4% | 906.1% | 424.0% | 1,789.7% | 84.0% | 5,201.6% | 14,081.6% | 31,937.5% |
| 稅後淨利 | −8.2M-163% | −1.5M-89% | −3.7M-68% | −17.2M-76% | 13.0M-1422% | −14.1M+284% | −11.4M+56% | −72.1M+1241% | −983K | −3.7M | −7.3M | −5.4M |
| 淨利率 | – | 355.9% | 803.5% | 3,346.4% | -2,040.7% | 4,807.8% | 1,711.2% | 23,950.8% | 88.0% | 6,013.1% | 14,965.3% | 33,593.8% |
| 稀釋 EPS | -0.09-119% | -0.06-89% | -0.13-70% | -0.63-78% | 0.48-1300% | -0.53+231% | -0.43+39% | -2.90+1161% | -0.04 | -0.16 | -0.31 | -0.23 |
| 稀釋股數 | 91.0M | 27.5M | 27.5M | 27.5M | 27.3M | 26.6M | 26.5M | 24.8M | 23.4M | 23.4M | 23.4M | 23.4M |
資產負債表 期末餘額
| 科目 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 800K | 200K | 200K | 200K | – | 1.0M | 1.1M | – | – | – | – | 0 |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.6M | 902K | 1.1M | 1.9M | 2.9M | 1.0M | 2.2M | 306K | 1.8M | 109M | 109M | 108M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 94.0M | 98.5M | 97.4M | 94.6M | 78.7M | 76.3M | 63.8M | 55.1M | 12.7M | 5.2M | 3.7M | 3.3M |
| 股東權益 | −92.4M | −97.6M | −96.3M | −92.7M | −75.8M | −75.2M | −61.7M | −54.8M | −10.8M | −9.8M | −9.5M | −7.5M |
| 負債比 | 5,940.6% | 10,922.2% | 8,603.6% | 5,110.4% | 2,672.4% | 7,396.2% | 2,953.2% | 17,993.1% | 687.4% | 4.8% | 3.4% | 3.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −356K-27% | – | – | – | −485K | – | – | −2.7M+622% | – | – | – | −367K |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2024 | −2.0M | +16.1% | −9.5M | 463.3% | -0.34 | – |
| FY2023 | −1.8M | +41.8% | −114M | 6,496.4% | -4.35 | – |
| FY2022 | −1.2M | – | −17.4M | 1,396.5% | -0.74 | – |